Antimicrob Agents Chemother

1. UPTON CM, Calderin JM, Diacon AH, Boeree MJ, et al
   Cerebrospinal fluid penetration of cycloserine/terizidone and clofazimine in patients with pulmonary TB.
   Antimicrob Agents Chemother. 2025;69:e0093125.
   

   >> Share

   
   

   
   Clin Infect Dis

2. MCCREESH N, MacPherson P, Bampi JVB, Engel N, et al
   Reported Tuberculosis Symptoms: An Inadequate Classifier of Disease State.
   Clin Infect Dis. 2025 Dec 10:ciaf611. doi: 10.1093.
   

   >> Share

   
   
3. DALE KD
   Why we should move away - not towards - symptom-based terminology and policy in tuberculosis.
   Clin Infect Dis. 2025 Dec 5:ciaf667. doi: 10.1093.
   

   >> Share

   
   

   
   Emerg Infect Dis

4. SEUNG KJ, Asfaw M, Kunda M, Maama-Maime LB, et al
   Extensively Drug-Resistant Tuberculosis with Conflicting Resistance Testing Results, Lesotho.
   Emerg Infect Dis. 2025;31:2185-2187.
   

   >> Share

   
   

   
   J Clin Microbiol

5. FENG Z, Ge S, Miao P, Liu M, et al
   Diagnostic performance of the Sanity 2.0 assay to detect resistance to rifampicin, isoniazid, and fluoroquinolones in tuberculosis.
   J Clin Microbiol. 2025 Dec 10:e0129925. doi: 10.1128/jcm.01299.
   

   >> Share

   
   
6. OLABAMIJI JO, Ochei K, Daniel O, Eneogu R, et al
   Evaluation of stool-based testing to diagnose tuberculosis in children using the Truenat platform in routine settings in Nigeria.
   J Clin Microbiol. 2025 Dec 10:e0104125. doi: 10.1128/jcm.01041.
   

   >> Share

   
   

   
   J Infect Dis

7. ERNST JD
   Clinical Commentary on: Targeting Tryptophan Metabolism for Tuberculosis Biomarkers and Host Directed Therapy.
   J Infect Dis. 2025 Dec 11:jiaf624. doi: 10.1093.
   

   >> Share

   
   

   
   Lancet

8. LATEEF S
   Aid cuts hampering Nepal's tuberculosis care.
   Lancet. 2025 Dec 4:S0140-6736(25)02469-9. doi: 10.1016/S0140-6736(25)02469.
   

   >> Share

   
   

   
   PLoS One

9. OCTOBER CD, Baloyi DP, Viljoen L, Raad R, et al
   Using participatory methods to develop a narrative intervention to alleviate distress in children hospitalised with TB in South Africa: The DIMPle project.
   PLoS One. 2025;20:e0338394.
   

   >> Share

   
   
10. ASMAMAW B, Tadese TT, Mamo RY, Taye BA, et al
    Magnitude of tuberculosis treatment outcomes and associated factors in public health institutions of Arba Minch town, Southern Ethiopia: A multi-centered retrospective cross-sectional study.
    PLoS One. 2025;20:e0338393.
    

    >> Share

    
    
11. GETAHUN M, Kebede Y, Molalegn H, Alemu A, et al
    Contribution of xpert MTB/RIF assay and Urine LF-LAM for the diagnosis of tuberculosis in children aged 5 - 14 years, at selected health facilities in Ethiopia, 2016 - 2019.
    PLoS One. 2025;20:e0338557.
    

    >> Share

    
    
12. KATEETE DP, Namakula S, Kigozi E, Katabazi FA, et al
    Patterns of compensatory mutations in rpoA/B/C genes of multidrug resistant M. tuberculosis in Uganda.
    PLoS One. 2025;20:e0328957.
    

    >> Share

    
    

    
    Trop Med Int Health

13. BISWAS C, Supriya AS, Gandhi A, Pardeshi G, et al
    The Effect of Add-On Corticosteroids on Treatment Outcomes in Lymph Node Tuberculosis: A Systematic Review and Meta-Analysis.
    Trop Med Int Health. 2025 Dec 12. doi: 10.1111/tmi.70065.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share